Both are widely sold through research-chemical channels labeled not for human consumption, which means no license checked the buyer, no prescription was written, no compounding pharmacy touched the product, no one scheduled a follow-up, and no agency verified whats actually in the vial
Prevents bacterial growth for up to 28 days after first use
Matek D, Sikiric P, et al
How to Code Generalized Weakness: Step-by-Step Workflow Step 1: Document onset, duration, and progression The note must state: start date or timeframe worsening, stable, or improving course precipitating events (hospitalization, infection, immobility) Step 2: Record objective strength findings The record must include objective findings, not only patient statements
Side effects are comparable, though AOD 9604 has more clinical data supporting its safety profile